Literature DB >> 2932182

Combined thin layer chromatography/mass spectrometry: an application of 252Cf plasma desorption mass spectrometry for drug monitoring.

H Danigel, L Schmidt, H Jungclas, K H Pflüger.   

Abstract

The pharmacokinetic analysis is performed in a three-step procedure: sample extraction, sample purification by thin layer chromatography (TLC) and quantitative sample detection by time-of-flight (TOF) mass spectrometry. 252Cf plasma desorption (PD) mass spectrometry utilizing the fission fragment-induced ionization and desorption of non-volatile compounds is suitable as a universal, non-destructive detector in TLC. Here TLC and mass spectrometry are operated in an off-line combination. As an example some pharmacokinetic data for etoposide (VP 16-213) together with calibration data are presented. The new experimental method is discussed in terms of sensitivity and detection limit.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932182     DOI: 10.1002/bms.1200120917

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  3 in total

1.  Drug monitoring of etoposide (VP16-213). I. A combined method of liquid chromatography and mass spectrometry.

Authors:  H Danigel; K H Pflüger; H Jungclas; L Schmidt; J Dellbrügge
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions.

Authors:  K H Pflüger; M Hahn; J B Holz; L Schmidt; P Köhl; H W Fritsch; H Jungclas; K Havemann
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Metabolism of 14C-busulfan in isolated perfused rat liver.

Authors:  M Hassan; H Ehrsson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.